{
    "Trade/Device Name(s)": [
        "Healgen THC One Step Marijuana Test",
        "Healgen mAMP One Step Methamphetamine Test"
    ],
    "Submitter Information": "HEALGEN SCIENTIFIC LLC",
    "510(k) Number": "K140546",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ",
        "LAF"
    ],
    "Summary Letter Date": "June 6, 2014",
    "Summary Letter Received Date": "April 18, 2014",
    "Submission Date": "April 17, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.3870",
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Cannabinoid Test System",
        "Methamphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "11-nor-\u03949-THC-9-COOH",
        "Methamphetamine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow chromatographic immunoassay"
    ],
    "Methodologies": [
        "Competitive binding immunoassay"
    ],
    "Submission Type(s)": [
        "Strip test",
        "Cassette",
        "Dip card",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Healgen THC and mAMP One Step tests for qualitative detection of marijuana metabolite and methamphetamine in urine using immunochromatographic lateral flow technology",
    "Indications for Use Summary": "Qualitative determination of 11-nor-\u03949-THC-9-COOH and methamphetamine in human urine at specified cut-off concentrations, intended for in vitro diagnostic, over-the-counter and prescription use in strip, cassette, dip card, and cup formats",
    "fda_folder": "Toxicology"
}